Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 300

1.

Gastrointestinal tract dysbiosis enhances distal tumor progression through suppression of leukocyte trafficking.

Jenkins SV, Robeson MS, Griffin RJ, Quick CM, Siegel ER, Cannon MJ, Vang KB, Dings RPM.

Cancer Res. 2019 Oct 7. pii: canres.4108.2019. doi: 10.1158/0008-5472.CAN-18-4108. [Epub ahead of print]

PMID:
31591154
2.

Selective DNA-PKcs inhibition extends the therapeutic index of localized radiotherapy and chemotherapy.

Willoughby CE, Jiang Y, Thomas HD, Willmore E, Kyle S, Wittner A, Phillips N, Zhao Y, Tudhope SJ, Prendergast L, Junge G, Madia Lourenco L, Finlay MRV, Turner P, Munck JM, Griffin RJ, Rennison T, Pickles J, Cano C, Newell DR, Reeves HL, Ryan AJ, Wedge SR.

J Clin Invest. 2019 Oct 3. pii: 127483. doi: 10.1172/JCI127483. [Epub ahead of print]

3.

Three discipline collaborative radiation therapy (3DCRT) special debate: The United States needs at least one carbon ion facility.

Blakely EA, Faddegon B, Tinkle C, Bloch C, Dominello M, Griffin RJ, Joiner MC, Burmeister J.

J Appl Clin Med Phys. 2019 Nov;20(11):6-13. doi: 10.1002/acm2.12727. Epub 2019 Oct 1. No abstract available.

PMID:
31573146
4.

Plasmonic Nanofactors as Switchable Devices to Promote or Inhibit Neuronal Activity and Function.

Alghazali KM, Hamzah RN, Nima ZA, Steiner R, Dhar M, Anderson DE, Hayar A, Griffin RJ, Biris AS.

Nanomaterials (Basel). 2019 Jul 18;9(7). pii: E1029. doi: 10.3390/nano9071029. Review.

5.

Technology-Based Mental Health Treatment and the Impact on the Therapeutic Alliance.

Lopez A, Schwenk S, Schneck CD, Griffin RJ, Mishkind MC.

Curr Psychiatry Rep. 2019 Jul 8;21(8):76. doi: 10.1007/s11920-019-1055-7. Review.

PMID:
31286280
6.

Identification of a novel orally bioavailable ERK5 inhibitor with selectivity over p38α and BRD4.

Myers SM, Miller DC, Molyneux L, Arasta M, Bawn RH, Blackburn TJ, Cook SJ, Edwards N, Endicott JA, Golding BT, Griffin RJ, Hammonds T, Hardcastle IR, Harnor SJ, Heptinstall AB, Lochhead PA, Martin MP, Martin NC, Newell DR, Owen PJ, Pang LC, Reuillon T, Rigoreau LJM, Thomas HD, Tucker JA, Wang LZ, Wong AC, Noble MEM, Wedge SR, Cano C.

Eur J Med Chem. 2019 Sep 15;178:530-543. doi: 10.1016/j.ejmech.2019.05.057. Epub 2019 May 25.

PMID:
31212132
7.

Reoxygenation and Repopulation of Tumor Cells after Ablative Hypofractionated Radiotherapy (SBRT and SRS) in Murine Tumors.

Song CW, Griffin RJ, Lee YJ, Cho H, Seo J, Park I, Kim HK, Kim DH, Kim MS, Dusenbery KE, Cho LC.

Radiat Res. 2019 Aug;192(2):159-168. doi: 10.1667/RR15346.1. Epub 2019 Jun 12.

PMID:
31188068
8.

Reply to Flugge: The anti-metastatic potential of methionine restriction in melanoma.

Miousse IR, Tobacyk J, Quick CM, Jamshidi-Parsian A, Skinner CM, Kore R, Melnyk SB, Kutanzi KR, Xia F, Griffin RJ, Koturbash I.

Carcinogenesis. 2019 May 29. pii: bgz099. doi: 10.1093/carcin/bgz099. [Epub ahead of print] No abstract available.

PMID:
31140558
9.

Enhanced Photothermal Treatment Efficacy and Normal Tissue Protection via Vascular Targeted Gold Nanocages.

Jenkins SV, Nedosekin DA, Shaulis BJ, Wang T, Jamshidi-Parsian A, Pollock ED, Chen J, Dings RPM, Griffin RJ.

Nanotheranostics. 2019 Mar 22;3(2):145-155. doi: 10.7150/ntno.32395. eCollection 2019.

10.

Bouncier Particles at Night: Biogenic Secondary Organic Aerosol Chemistry and Sulfate Drive Diel Variations in the Aerosol Phase in a Mixed Forest.

Slade JH, Ault AP, Bui AT, Ditto JC, Lei Z, Bondy AL, Olson NE, Cook RD, Desrochers SJ, Harvey RM, Erickson MH, Wallace HW, Alvarez SL, Flynn JH, Boor BE, Petrucci GA, Gentner DR, Griffin RJ, Shepson PB.

Environ Sci Technol. 2019 May 7;53(9):4977-4987. doi: 10.1021/acs.est.8b07319. Epub 2019 Apr 24.

PMID:
31002496
11.

Harnessing epigenetics and metabolism to modulate tissue response to radiotherapy.

Koturbash I, Griffin RJ.

Int J Radiat Biol. 2019 Apr;95(4):379-381. doi: 10.1080/09553002.2019.1587268. Epub 2019 Mar 11. No abstract available.

PMID:
30856046
12.

Label-Free Raman Spectroscopy Reveals Signatures of Radiation Resistance in the Tumor Microenvironment.

Paidi SK, Diaz PM, Dadgar S, Jenkins SV, Quick CM, Griffin RJ, Dings RPM, Rajaram N, Barman I.

Cancer Res. 2019 Apr 15;79(8):2054-2064. doi: 10.1158/0008-5472.CAN-18-2732. Epub 2019 Feb 28.

PMID:
30819665
13.

Three discipline collaborative radiation therapy (3DCRT) special debate: I would treat all early-stage NSCLC patients with SBRT.

Mohindra P, Sawant A, Griffin RJ, Lamichhane N, Vlashi E, Xu-Welliver M, Dominello M, Joiner MC, Burmeister J.

J Appl Clin Med Phys. 2019 Mar;20(3):7-13. doi: 10.1002/acm2.12545. Epub 2019 Feb 22. No abstract available.

14.

Sample storage conditions induce post-collection biases in microbiome profiles.

Jenkins SV, Vang KB, Gies A, Griffin RJ, Jun SR, Nookaew I, Dings RPM.

BMC Microbiol. 2018 Dec 27;18(1):227. doi: 10.1186/s12866-018-1359-5.

15.

Glutaminase inhibitor CB-839 increases radiation sensitivity of lung tumor cells and human lung tumor xenografts in mice.

Boysen G, Jamshidi-Parsian A, Davis MA, Siegel ER, Simecka CM, Kore RA, Dings RPM, Griffin RJ.

Int J Radiat Biol. 2019 Apr;95(4):436-442. doi: 10.1080/09553002.2018.1558299. Epub 2019 Jan 15.

PMID:
30557074
16.

Rapid quantification of mitochondrial fractal dimension in individual cells.

Vargas I, Alhallak K, Kolenc OI, Jenkins SV, Griffin RJ, Dings RPM, Rajaram N, Quinn KP.

Biomed Opt Express. 2018 Oct 9;9(11):5269-5279. doi: 10.1364/BOE.9.005269. eCollection 2018 Nov 1.

17.

Quantitative diffuse reflectance spectroscopy of short-term changes in tumor oxygenation after radiation in a matched model of radiation resistance.

Diaz PM, Jenkins SV, Alhallak K, Semeniak D, Griffin RJ, Dings RPM, Rajaram N.

Biomed Opt Express. 2018 Jul 24;9(8):3794-3804. doi: 10.1364/BOE.9.003794. eCollection 2018 Aug 1.

18.

Tumor-endothelial cell interaction in an experimental model of human hepatocellular carcinoma.

Jamshidi-Parsian A, Griffin RJ, Kore RA, Todorova VK, Makhoul I.

Exp Cell Res. 2018 Nov 1;372(1):16-24. doi: 10.1016/j.yexcr.2018.09.001. Epub 2018 Sep 8.

PMID:
30205087
19.

Quantitative microinjection using fluorescence calibration of streaming microdroplets on a superhydrophobic surface.

Moore CL, Taylor EM, Ball KK, Bernock LJ, Griffin RJ, Jung S, Shoeib A, Borrelli MJ.

Exp Cell Res. 2018 Sep 15;370(2):426-433. doi: 10.1016/j.yexcr.2018.07.006. Epub 2018 Jul 4.

PMID:
29981341
20.

DNA Methylation in Radiation-Induced Carcinogenesis: Experimental Evidence and Clinical Perspectives.

Miousse IR, Ewing LE, Kutanzi KR, Griffin RJ, Koturbash I.

Crit Rev Oncog. 2018;23(1-2):1-11. doi: 10.1615/CritRevOncog.2018025687. Review.

21.

Modulation of dietary methionine intake elicits potent, yet distinct, anticancer effects on primary versus metastatic tumors.

Miousse IR, Tobacyk J, Quick CM, Jamshidi-Parsian A, Skinner CM, Kore R, Melnyk SB, Kutanzi KR, Xia F, Griffin RJ, Koturbash I.

Carcinogenesis. 2018 Sep 21;39(9):1117-1126. doi: 10.1093/carcin/bgy085.

22.

A Radiosensitizing Inhibitor of HIF-1 alters the Optical Redox State of Human Lung Cancer Cells In Vitro.

Lee DE, Alhallak K, Jenkins SV, Vargas I, Greene NP, Quinn KP, Griffin RJ, Dings RPM, Rajaram N.

Sci Rep. 2018 Jun 11;8(1):8815. doi: 10.1038/s41598-018-27262-y.

23.

Hypoxia-derived exosomes induce putative altered pathways in biosynthesis and ion regulatory channels in glioblastoma cells.

Kore RA, Edmondson JL, Jenkins SV, Jamshidi-Parsian A, Dings RPM, Reyna NS, Griffin RJ.

Biochem Biophys Rep. 2018 May 2;14:104-113. doi: 10.1016/j.bbrep.2018.03.008. eCollection 2018 Jul.

24.

Triple-negative breast cancer targeting and killing by EpCAM-directed, plasmonically active nanodrug systems.

Jenkins SV, Nima ZA, Vang KB, Kannarpady G, Nedosekin DA, Zharov VP, Griffin RJ, Biris AS, Dings RPM.

NPJ Precis Oncol. 2017 Sep 1;1(1):27. doi: 10.1038/s41698-017-0030-1. eCollection 2017.

25.

Consensus guidelines for the use and interpretation of angiogenesis assays.

Nowak-Sliwinska P, Alitalo K, Allen E, Anisimov A, Aplin AC, Auerbach R, Augustin HG, Bates DO, van Beijnum JR, Bender RHF, Bergers G, Bikfalvi A, Bischoff J, Böck BC, Brooks PC, Bussolino F, Cakir B, Carmeliet P, Castranova D, Cimpean AM, Cleaver O, Coukos G, Davis GE, De Palma M, Dimberg A, Dings RPM, Djonov V, Dudley AC, Dufton NP, Fendt SM, Ferrara N, Fruttiger M, Fukumura D, Ghesquière B, Gong Y, Griffin RJ, Harris AL, Hughes CCW, Hultgren NW, Iruela-Arispe ML, Irving M, Jain RK, Kalluri R, Kalucka J, Kerbel RS, Kitajewski J, Klaassen I, Kleinmann HK, Koolwijk P, Kuczynski E, Kwak BR, Marien K, Melero-Martin JM, Munn LL, Nicosia RF, Noel A, Nurro J, Olsson AK, Petrova TV, Pietras K, Pili R, Pollard JW, Post MJ, Quax PHA, Rabinovich GA, Raica M, Randi AM, Ribatti D, Ruegg C, Schlingemann RO, Schulte-Merker S, Smith LEH, Song JW, Stacker SA, Stalin J, Stratman AN, Van de Velde M, van Hinsbergh VWM, Vermeulen PB, Waltenberger J, Weinstein BM, Xin H, Yetkin-Arik B, Yla-Herttuala S, Yoder MC, Griffioen AW.

Angiogenesis. 2018 Aug;21(3):425-532. doi: 10.1007/s10456-018-9613-x. Review.

26.

Galectins as Molecular Targets for Therapeutic Intervention.

Dings RPM, Miller MC, Griffin RJ, Mayo KH.

Int J Mol Sci. 2018 Mar 19;19(3). pii: E905. doi: 10.3390/ijms19030905. Review.

27.

Galectin-1 Inhibitor OTX008 Induces Tumor Vessel Normalization and Tumor Growth Inhibition in Human Head and Neck Squamous Cell Carcinoma Models.

Koonce NA, Griffin RJ, Dings RPM.

Int J Mol Sci. 2017 Dec 9;18(12). pii: E2671. doi: 10.3390/ijms18122671.

28.

The Future of Radiobiology.

Kirsch DG, Diehn M, Kesarwala AH, Maity A, Morgan MA, Schwarz JK, Bristow R, Demaria S, Eke I, Griffin RJ, Haas-Kogan D, Higgins GS, Kimmelman AC, Kimple RJ, Lombaert IM, Ma L, Marples B, Pajonk F, Park CC, Schaue D, Tran PT, Willers H, Wouters BG, Bernhard EJ.

J Natl Cancer Inst. 2018 Apr 1;110(4):329-340. doi: 10.1093/jnci/djx231.

29.

Real-time monitoring of circulating tumor cell (CTC) release after nanodrug or tumor radiotherapy using in vivo flow cytometry.

Koonce NA, Juratli MA, Cai C, Sarimollaoglu M, Menyaev YA, Dent J, Quick CM, Dings RPM, Nedosekin D, Zharov V, Griffin RJ.

Biochem Biophys Res Commun. 2017 Oct 21;492(3):507-512. doi: 10.1016/j.bbrc.2017.08.053. Epub 2017 Aug 16.

30.

Modifying Dendritic Cell Activation with Plasmonic Nano Vectors.

Vang KB, Safina I, Darrigues E, Nedosekin D, Nima ZA, Majeed W, Watanabe F, Kannarpady G, Kore RA, Casciano D, Zharov VP, Griffin RJ, Dings RPM, Biris AS.

Sci Rep. 2017 Jul 14;7(1):5513. doi: 10.1038/s41598-017-04459-1.

31.

Optical imaging of radiation-induced metabolic changes in radiation-sensitive and resistant cancer cells.

Alhallak K, Jenkins SV, Lee DE, Greene NP, Quinn KP, Griffin RJ, Dings RPM, Rajaram N.

J Biomed Opt. 2017 Jun 1;22(6):60502. doi: 10.1117/1.JBO.22.6.060502.

32.

Galectin-1-based tumour-targeting for gold nanostructure-mediated photothermal therapy.

Jenkins SV, Nedosekin DA, Miller EK, Zharov VP, Dings RPM, Chen J, Griffin RJ.

Int J Hyperthermia. 2018 Feb;34(1):19-29. doi: 10.1080/02656736.2017.1317845. Epub 2017 May 9.

33.

Further rationale for optimal combined modality treatments.

Griffin RJ, Dings RPM, Makhoul I.

Oncotarget. 2017 Apr 18;8(16):25831-25832. doi: 10.18632/oncotarget.16117. No abstract available.

34.

Study of Image Qualities From 6D Robot-Based CBCT Imaging System of Small Animal Irradiator.

Sharma S, Narayanasamy G, Clarkson R, Chao M, Moros EG, Zhang X, Yan Y, Boerma M, Paudel N, Morrill S, Corry P, Griffin RJ.

Technol Cancer Res Treat. 2017 Jan 1:1533034617700558. doi: 10.1177/1533034617700558. [Epub ahead of print]

35.

Raman spectroscopy using plasmonic and carbon-based nanoparticles for cancer detection, diagnosis, and treatment guidance. Part 2: Treatment.

Darrigues E, Dantuluri V, Nima ZA, Vang-Dings KB, Griffin RJ, Biris AR, Ghosh A, Biris AS.

Drug Metab Rev. 2017 May;49(2):253-283. doi: 10.1080/03602532.2017.1307387. Epub 2017 Jun 19.

PMID:
28298144
36.

Overview of surface measurements and spatial characterization of submicrometer particulate matter during the DISCOVER-AQ 2013 campaign in Houston, TX.

Leong YJ, Sanchez NP, Wallace HW, Karakurt Cevik B, Hernandez CS, Han Y, Flynn JH, Massoli P, Floerchinger C, Fortner EC, Herndon S, Bean JK, Hildebrandt Ruiz L, Jeon W, Choi Y, Lefer B, Griffin RJ.

J Air Waste Manag Assoc. 2017 Aug;67(8):854-872. doi: 10.1080/10962247.2017.1296502. Epub 2017 Feb 28.

PMID:
28278029
37.

Raman spectroscopy using plasmonic and carbon-based nanoparticles for cancer detection, diagnosis, and treatment guidance.Part 1: Diagnosis.

Darrigues E, Nima ZA, Majeed W, Vang-Dings KB, Dantuluri V, Biris AR, Zharov VP, Griffin RJ, Biris AS.

Drug Metab Rev. 2017 May;49(2):212-252. doi: 10.1080/03602532.2017.1302465. Epub 2017 Jun 15. Review.

PMID:
28264609
38.

Vehicle Emissions as an Important Urban Ammonia Source in the United States and China.

Sun K, Tao L, Miller DJ, Pan D, Golston LM, Zondlo MA, Griffin RJ, Wallace HW, Leong YJ, Yang MM, Zhang Y, Mauzerall DL, Zhu T.

Environ Sci Technol. 2017 Feb 21;51(4):2472-2481. doi: 10.1021/acs.est.6b02805. Epub 2017 Jan 31.

PMID:
28140570
39.

Germline Genetic Variants in TEK, ANGPT1, ANGPT2, MMP9, FGF2 and VEGFA Are Associated with Pathologic Complete Response to Bevacizumab in Breast Cancer Patients.

Makhoul I, Todorova VK, Siegel ER, Erickson SW, Dhakal I, Raj VR, Lee JY, Orloff MS, Griffin RJ, Henry-Tillman RS, Klimberg S, Hutchins LF, Kadlubar SA.

PLoS One. 2017 Jan 3;12(1):e0168550. doi: 10.1371/journal.pone.0168550. eCollection 2017.

40.

Nitrate radicals and biogenic volatile organic compounds: oxidation, mechanisms, and organic aerosol.

Ng NL, Brown SS, Archibald AT, Atlas E, Cohen RC, Crowley JN, Day DA, Donahue NM, Fry JL, Fuchs H, Griffin RJ, Guzman MI, Herrmann H, Hodzic A, Iinuma Y, Jimenez JL, Kiendler-Scharr A, Lee BH, Luecken DJ, Mao J, McLaren R, Mutzel A, Osthoff HD, Ouyang B, Picquet-Varrault B, Platt U, Pye HOT, Rudich Y, Schwantes RH, Shiraiwa M, Stutz J, Thornton JA, Tilgner A, Williams BJ, Zaveri RA.

Atmos Chem Phys. 2017;17(3):2103-2162. doi: 10.5194/acp-17-2103-2017.

41.

Cyclin-Dependent Kinase (CDK) Inhibitors: Structure-Activity Relationships and Insights into the CDK-2 Selectivity of 6-Substituted 2-Arylaminopurines.

Coxon CR, Anscombe E, Harnor SJ, Martin MP, Carbain B, Golding BT, Hardcastle IR, Harlow LK, Korolchuk S, Matheson CJ, Newell DR, Noble ME, Sivaprakasam M, Tudhope SJ, Turner DM, Wang LZ, Wedge SR, Wong C, Griffin RJ, Endicott JA, Cano C.

J Med Chem. 2017 Mar 9;60(5):1746-1767. doi: 10.1021/acs.jmedchem.6b01254. Epub 2017 Feb 14.

42.

In Vivo Flow Cytometry of Circulating Tumor-Associated Exosomes.

Nolan J, Sarimollaoglu M, Nedosekin DA, Jamshidi-Parsian A, Galanzha EI, Kore RA, Griffin RJ, Zharov VP.

Anal Cell Pathol (Amst). 2016;2016:1628057. Epub 2016 Nov 14.

43.

Scientific uncertainty in media content: Some reflections on this special issue.

Griffin RJ.

Public Underst Sci. 2016 Nov;25(8):1009-1013. No abstract available.

PMID:
27856829
44.

Structure-guided design of purine-based probes for selective Nek2 inhibition.

Coxon CR, Wong C, Bayliss R, Boxall K, Carr KH, Fry AM, Hardcastle IR, Matheson CJ, Newell DR, Sivaprakasam M, Thomas H, Turner D, Yeoh S, Wang LZ, Griffin RJ, Golding BT, Cano C.

Oncotarget. 2017 Mar 21;8(12):19089-19124. doi: 10.18632/oncotarget.13249.

45.

A new tool for the chemical genetic investigation of the Plasmodium falciparum Pfnek-2 NIMA-related kinase.

Mitcheson DF, Bottrill AR, Carr K, Coxon CR, Cano C, Golding BT, Griffin RJ, Fry AM, Doerig C, Bayliss R, Tobin AB.

Malar J. 2016 Nov 7;15(1):535.

46.

New derivatives of the antimalarial drug Pyrimethamine in the control of melanoma tumor growth: an in vitro and in vivo study.

Tommasino C, Gambardella L, Buoncervello M, Griffin RJ, Golding BT, Alberton M, Macchia D, Spada M, Cerbelli B, d'Amati G, Malorni W, Gabriele L, Giammarioli AM.

J Exp Clin Cancer Res. 2016 Sep 6;35(1):137. doi: 10.1186/s13046-016-0409-9.

47.

Modelling responses to spatially fractionated radiation fields using preclinical image-guided radiotherapy.

Butterworth KT, Ghita M, McMahon SJ, Mcgarry CK, Griffin RJ, Hounsell AR, Prise KM.

Br J Radiol. 2017 Jan;90(1069):20160485. doi: 10.1259/bjr.20160485. Epub 2016 Sep 15.

48.

Combined PI3K and CDK2 inhibition induces cell death and enhances in vivo antitumour activity in colorectal cancer.

Beale G, Haagensen EJ, Thomas HD, Wang LZ, Revill CH, Payne SL, Golding BT, Hardcastle IR, Newell DR, Griffin RJ, Cano C.

Br J Cancer. 2016 Sep 6;115(6):682-90. doi: 10.1038/bjc.2016.238. Epub 2016 Aug 16.

49.

Mid-infrared dual-gas sensor for simultaneous detection of methane and ethane using a single continuous-wave interband cascade laser.

Ye W, Li C, Zheng C, Sanchez NP, Gluszek AK, Hudzikowski AJ, Dong L, Griffin RJ, Tittel FK.

Opt Express. 2016 Jul 25;24(15):16973-85. doi: 10.1364/OE.24.016973.

PMID:
27464149
50.

Signatures of Biomass Burning Aerosols in the Plume of a Saltmarsh Wildfire in South Texas.

Myers-Pigg AN, Griffin RJ, Louchouarn P, Norwood MJ, Sterne A, Cevik BK.

Environ Sci Technol. 2016 Sep 6;50(17):9308-14. doi: 10.1021/acs.est.6b02132. Epub 2016 Aug 9.

PMID:
27462728

Supplemental Content

Loading ...
Support Center